Stirling Products

Shares in Stirling Products have been placed in a trading halt pending the announcement of a significant acquisition.

PERTH-BASED Stirling Products Ltd has bought the worldwide licensing rights for the pet food product PetQuench, with sales of more than $25 million expected during the first five years.

Perth-based biotechnology company Stirling Products Ltd has signed a deal with an American distributor to include their immune system-booster ProVale in their animal performance diet products, the company has announced.

Perth-based biotechnology company Stirling Products Ltd has commenced the second stage of trials of the R-salbutamol growth agent in barramundi, and is nearing the completion of trals on swine, the company has announced.

Perth-based biotechnology company Stirling Products Ltd will acquire Canada-based Progressive BioActives Incorporated for around $856,000 and 1.6 million shares, after confirming both parties signed an agreement today.

Perth-based biotechnology company Stirling Products Ltd has signed a deal with Danish company Equine HealthCare ApS, to establish a joint venture to develop technology to treat heaves, an equine respiratory disease.

Perth headquartered biotechnology company Stirling Products Ltd has finalised a $1.3 million placement to US institutional investor, Indus Capital Partners, LLC, to fund the further development of R-salbutamol as a growth agent and in obesity applications

Advises that 36,000,000 ordinary shares will be released from escrow arrangements on 23 February 2006.

Listed biotechnology company Stirling Products has appointed Gunnar Aberg to its board.

4,000,000 ordinary fully paid shares were released from escrow on February 18